Alkermes ALKS Accrued Sales Discounts Allowances And Reserves
Accrued Sales Discounts Allowances And Reserves at other companies
Other financials
Where this comes from
Reported directly by Alkermes in its filing.
Tagged under the XBRL concept alks:AccruedSalesDiscountsAllowancesAndReserves.
The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alkermes's accrued sales discounts allowances and reserves.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alkermes's accrued sales discounts allowances and reserves?
- Alkermes (ALKS) reported accrued sales discounts allowances and reserves of $272.84M in Q1 2026.
- How has Alkermes's accrued sales discounts allowances and reserves changed year-over-year?
- Alkermes's accrued sales discounts allowances and reserves increased by 9.2% year-over-year, from $249.8M to $272.84M.
- What is the long-term trend for Alkermes's accrued sales discounts allowances and reserves?
- Over 4 years (2021 to 2025), Alkermes's accrued sales discounts allowances and reserves has grown at a 1.0% compound annual growth rate (CAGR), from $237.22M to $247.13M.
- What does accrued sales discounts allowances and reserves mean?
- This represents estimated liabilities for rebates, chargebacks, and discounts owed to customers or distributors based on sales activity. It is critical for pharmaceutical companies to accurately estimate these contra-revenue items to reflect net revenue correctly.